Monsanto Co. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co.

MTC 2.820

+0.7%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dan Spillane who wrote (1040)	2/1/1999 7:46:00 PM
From: Anthony Wong	Read Replies (1) of 2539

02/01 18:01 IMS says 9,500 Celebrex prescriptions dispensed NEW YORK, Feb 1 (Reuters) - IMS Health <RX.N> said Monday that recently approved arthritis drug Celebrex, which is co-marketed by Pfizer Inc. <PFE.N> and GD Searle & Co. captured 9,527 dispensed total prescriptions in the U.S. for the week ending January 22. The drug, which was recently approved in the United States, is the first in a new class of drugs called Cox-2 inhibitors that are used to treat the symptoms of rheumatoid arthritis and osteoarthritis. IMS Health said in a statement that year-ending November 1998 U.S. sales for antiarthritics are $1.7 billion and total prescriptions dispensed are 70.5 million. moneynet.com@NEWS-P1&Index=0&HeadlineURL=../News/NewsHeadlines.asp&DISABLE_FORM=&NAVSVC=News\Company

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next